Prelude Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-18,653
| Closed | -$4.05M | – | 1826 |
|
|
2021
Q1 | $4.05M | Buy |
+18,653
| New | +$4.05M | 0.1% | 62 |
|
|
2020
Q1 | – | Sell |
-9,277
| Closed | -$970K | – | 1782 |
|
|
2019
Q4 | $970K | Buy |
9,277
+9,147
| +7,036% | +$956K | 0.04% | 202 |
|
|
2019
Q3 | $15K | Sell |
130
-14
| -10% | -$1.62K | ﹤0.01% | 975 |
|
|
2019
Q2 | $25K | Sell |
144
-935
| -87% | -$162K | ﹤0.01% | 897 |
|
|
2019
Q1 | $182K | Sell |
1,079
-2,141
| -66% | -$361K | 0.01% | 475 |
|
|
2018
Q4 | $314K | Buy |
3,220
+680
| +27% | +$66.3K | 0.02% | 397 |
|
|
2018
Q3 | $439K | Sell |
2,540
-1,673
| -40% | -$289K | 0.03% | 366 |
|
|
2018
Q2 | $588K | Sell |
4,213
-930
| -18% | -$130K | 0.04% | 373 |
|
|
2018
Q1 | $579K | Buy |
5,143
+2,151
| +72% | +$242K | 0.04% | 353 |
|
|
2017
Q4 | $395K | Buy |
+2,992
| New | +$395K | 0.03% | 418 |
|
|
2016
Q4 | – | Sell |
-2,483
| Closed | -$330K | – | 1810 |
|
|
2016
Q3 | $330K | Buy |
+2,483
| New | +$330K | 0.03% | 363 |
|
|
2013
Q4 | – | Sell |
-11,000
| Closed | -$191K | – | 1885 |
|
|
2013
Q3 | $191K | Buy |
+11,000
| New | +$191K | 0.03% | 486 |
|